---
category: news
title: "Lantern and Deep Lens partner to expedite Phase II NSCLC trial enrolment"
excerpt: "Lantern Pharma has signed a strategic partnership with Deep Lens to accelerate enrolment in the formerâ€™s Phase II clinical trial of LP-300 plus chemotherapy to treat never-smokers with non-small cell lung cancer (NSCLC)."
publishedDateTime: 2021-09-29T10:54:00Z
originalUrl: "https://www.clinicaltrialsarena.com/news/lantern-deep-lens-partner-to-speed-up-phase-ii-nsclc-trial-enrolment/"
webUrl: "https://www.clinicaltrialsarena.com/news/lantern-deep-lens-partner-to-speed-up-phase-ii-nsclc-trial-enrolment/"
type: article
quality: 23
heat: 23
published: false

provider:
  name: Clinical Trials Arena
  domain: clinicaltrialsarena.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.clinicaltrialsarena.com/wp-content/uploads/sites/33/2021/09/Lantern.jpg"
    width: 1920
    height: 1280
    isCached: true

secured: "qsjnL/FKTPFrTLftazD3Zb3o8LMPBXfk8MA48TkSZEam6A1FPYbrL9oMmb21Xnhej8xTtVqwNdLAlnZ5wbgc5Kca3gZzUsQ1SHDmFQIYodcsXSQekk37W0A0wWCilvwN74iLlWWPxqkxlqGUNkzFeEPHLzlrJ77qrfzP0CK07eTzu+6IVmWWarHlvp3F3cKuIZsWx6+zDC8DgP2z/MWyF+uCCyjBUBgAjw97w0ZMuAauhX7UU4Jit7QOhoeZre2+zR7aZ+cYHt5Cfl2BzkrLw9TzhV+CrsMu+Uzfc8QhyKTacMjxgoAReoSBjKdLRXTFnGOKjqIP19njmuCAfSlail5hgJXgbz/MZzFZLgLmv60=;yokRWqbCVhO2IYP9mZMhfw=="
---

